3-Aminophthalhydrazide (Luminol) As a Matrix for Dual-Polarity MALDI MS Imaging

In many aspects of the matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) technique, the discovery of new MALDI matrixes has been a major task for the improvement of ionization efficiency, signal intensity, and molecular coverage. In this work, five analog compounds, including phthalhydrazide, 3-aminophthalhydrazide (3-APH or luminol) and its sodium salt, 4-aminophthalhydrazide (4-APH), and 3-nitrophthalhydrazide (3-NPH) were evaluated as potential matrixes for MALDI Fourier-transform ion cyclotron resonance (FTICR) MSI of metabolites in mouse brain tissue. The five candidate MALDI matrixes were mainly evaluated according to the solid-state ultraviolet absorption, the ion yields and species, and the dual-polarity detection. Among the five candidate matrixes, 3-APH and its sodium salt enabled the detection of endogenous metabolites better than the three other candidates in dual polarities. The best results were observed with 3-APH. Compared with commonly used MALDI matrixes such as 2,5-dihydroxybenzoic acid, alpha-cyano-4-hydroxycinnamic acid, and 9-aminoacridine, 3-APH exhibited superior performance in dual polarity MALDI MSI, higher sensitivity, broader molecular coverage, and lower background noise. The use of 3-APH led to on-tissue MALDI FTICR MSI of 159 and 207 mouse brain metabolites in the positive and negative ion modes, respectively. Among these metabolites, nucleotides, fatty acids, glycerolipids, glycerophospholipids, sphingolipids, and saccharolipids are included. 3-APH was further used for MALDI FTICR MSI of metabolic responses to ischemia-induced disturbances in mouse brain subjected to middle cerebral artery occlusion (MCAO), thus revealing the alteration of 105 metabolites in the ipsilateral hemispheres. This further emphasizes the great potential of 3-APH as a matrix for the localization of biomarkers in brain diseases.